-
1 Comment
HOYA Corporation is currently in a long term uptrend where the price is trading 10.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.3.
HOYA Corporation's total revenue rose by 1.1% to $150B since the same quarter in the previous year.
Its net income has increased by 24.2% to $37B since the same quarter in the previous year.
Finally, its free cash flow grew by 9.8% to $32B since the same quarter in the previous year.
Based on the above factors, HOYA Corporation gets an overall score of 5/5.
| Industry | Medical Instruments & Supplies |
|---|---|
| ISIN | JP3837800006 |
| Sector | Healthcare |
| Exchange | F |
| CurrencyCode | EUR |
| Target Price | 4000 |
|---|---|
| Dividend Yield | 0.8% |
| PE Ratio | 33.06 |
| Beta | 0.59 |
| Market Cap | 38B |
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Information Technology, and Other. It offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics. The company also operates Eyecity, a specialty retailer of contact lenses. In addition, it provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, the company engages in the research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. Additionally, it offers ReadSpeaker, a speech synthesis software. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HYB.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
